C79.19
Secondary malignant neoplasm of other urinary organs
Clinical Classification Guidelines
Medical Intelligence & Overview
Secondary malignant neoplasm of other urinary organs, classified under ICD-10 code C79.19, refers to cancer that has spread to the urinary organs from a primary site located elsewhere in the body. This condition is a type of metastatic cancer, indicating that cancer cells have traveled from their original location to infect other parts of the urinary system, which includes organs like the bladder, ureters, or other parts of the urinary tract. Recognizing and understanding this condition is crucial for appropriate diagnosis, treatment planning, and managing patient care.
Causes & Symptoms
Clinical Causes: Presence of primary cancer located in a different part of the body that has metastasized to the urinary organs Spread of malignant cells through the bloodstream or lymphatic system Invasion of nearby tissues from a primary tumor that extends into urinary organs History of other cancers such as lung, breast, or gastrointestinal tumors that have spread to urinary tissues
Key Symptoms: Blood in the urine (hematuria) Pain or discomfort in the lower abdomen or back Unexplained weight loss Fatigue or weakness Frequent urination or a burning sensation during urination Urinary obstruction resulting in difficulty urinating
Diagnostic & Treatment
Diagnosis Path: Imaging tests such as computed tomography (CT) scans, magnetic resonance imaging (MRI), or positron emission tomography (PET) scans to identify abnormal growths and metastases Urinalysis to detect blood or abnormal cells in the urine Biopsy of the affected tissue to determine the presence and type of malignant cells Blood tests to assess overall health and organ function, including tumor markers if applicable Assessment of patient history for previous or known primary cancers
Treatment Protocols: Chemotherapy to target and kill cancer cells throughout the body Radiation therapy aimed at shrinking tumors or alleviating symptoms Surgical intervention to remove metastatic tumors or affected tissues when feasible Targeted therapies that attack specific molecules involved in cancer growth Immunotherapy to stimulate the immune system's response against cancer cells Supportive care to manage symptoms and improve quality of life
Clinical Advice & FAQs
Billing Guidance
Is C79.19 a billable ICD-10 code?
Yes, C79.19 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C79.19?
Clinical documentation must specify the nature of Secondary malignant neoplasm of other urinary organs and any associated comorbidities for accurate reporting.
Cite this Clinical Reference